SERA MEXC RealStocks
Own real SERA shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-15 22:03:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Sera Prognostics, Inc. (SERA) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $2.01, with a market capitalization of $79.94M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.56 to $3.85. This page covers its latest market performance, valuation, price trends and company information.
$79.94M | |
$1.96 | |
$2.09 | |
$1.94 | |
$1.98 | |
27.89K | |
26.24K | |
-- | |
$3.85 | |
$1.56 | |
-- | |
-- |
Sera Prognostics, Inc. (SERA) last closed at $2.01 as of 2026-11-13 23:34:00, up 2.27% ($0.04) from the previous close of $1.98.
During the latest regular trading session, SERA traded between $1.94 and $2.09, with a volume of 27.89K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Sera Prognostics, Inc. (SERA) moved from $2.08 to $2.01, representing a decline of 3.51% ($0.07).
The stock traded between $1.91 and $2.22 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 65.25 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 19.5%
SERA is currently trading at $2.01, placing it 19.5% of the way from its 52-week low of $1.56 to its 52-week high of $3.85. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 72 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Sera Prognostics, Inc. (SERA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SERA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SERA shares and USD.
SERA Shares to USD
1.00 SERA shares = 2.007 USD
Calculations are estimates based on the latest available price and are for reference only.